BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koshkina NV, Kleinerman ES, Li G, Zhao CC, Wei Q, Sturgis EM. Exploratory analysis of Fas gene polymorphisms in pediatric osteosarcoma patients. J Pediatr Hematol Oncol 2007;29:815-21. [PMID: 18090928 DOI: 10.1097/MPH.0b013e3181581506] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Xie Y, Wang D, Xu H, Ye J, Yin JC, Chen J, Yan J, Ye B, Chen C. Whole exome sequencing identified a novel POT1 variant as a candidate pathogenic allele underlying a Li-Fraumeni-like family. Front Oncol 2022;12:963364. [PMID: 36387164 DOI: 10.3389/fonc.2022.963364] [Reference Citation Analysis]
2 Mai X, Qiu X, Yang Y, Ma Y. Impacts of Spectral Nudging Parameters on Dynamical Downscaling in Summer over Mainland China. Front Earth Sci 2020;8:574754. [DOI: 10.3389/feart.2020.574754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
3 Koshkina N, Yang Y, Kleinerman ES. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases. Adv Exp Med Biol 2020;1258:177-87. [PMID: 32767242 DOI: 10.1007/978-3-030-43085-6_12] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Chen Y, Wang H, Yan Y, Ren M, Yan C, Wang B. Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia. Medicine (Baltimore) 2019;98:e18240. [PMID: 31804351 DOI: 10.1097/MD.0000000000018240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Yang Y, Basu S, Mirabello L, Spector L, Zhang L. A Bayesian Gene-Based Genome-Wide Association Study Analysis of Osteosarcoma Trio Data Using a Hierarchically Structured Prior. Cancer Inform 2018;17:1176935118775103. [PMID: 29844655 DOI: 10.1177/1176935118775103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
6 Benna C, Simioni A, Pasquali S, De Boni D, Rajendran S, Spiro G, Colombo C, Virgone C, DuBois SG, Gronchi A, Rossi CR, Mocellin S. Genetic susceptibility to bone and soft tissue sarcomas: a field synopsis and meta-analysis. Oncotarget 2018;9:18607-26. [PMID: 29719630 DOI: 10.18632/oncotarget.24719] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
7 Yang Y, Huang G, Zhou Z, Fewell JG, Kleinerman ES. miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating FAS Promoter Activity and Can be Therapeutically Targeted to Inhibit Lung Metastases. Mol Cancer Ther 2018;17:130-9. [PMID: 29079708 DOI: 10.1158/1535-7163.MCT-17-0042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
8 Glover J, Man TK, Barkauskas DA, Hall D, Tello T, Sullivan MB, Gorlick R, Janeway K, Grier H, Lau C, Toretsky JA, Borinstein SC, Khanna C, Fan TM; COG Osteosarcoma Biology Group. Osteosarcoma enters a post genomic era with in silico opportunities: Generation of the High Dimensional Database for facilitating sarcoma biology research: A report from the Children's Oncology Group and the QuadW Foundation. PLoS One 2017;12:e0181204. [PMID: 28732082 DOI: 10.1371/journal.pone.0181204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gianferante DM, Mirabello L, Savage SA. Germline and somatic genetics of osteosarcoma - connecting aetiology, biology and therapy. Nat Rev Endocrinol 2017;13:480-91. [PMID: 28338660 DOI: 10.1038/nrendo.2017.16] [Cited by in Crossref: 213] [Cited by in F6Publishing: 234] [Article Influence: 35.5] [Reference Citation Analysis]
10 Jiang C, Chen H, Shao L, Dong Y. GRM4 gene polymorphism is associated with susceptibility and prognosis of osteosarcoma in a Chinese Han population. Med Oncol 2014;31:50. [PMID: 24984297 DOI: 10.1007/s12032-014-0050-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
11 Xu Y, He B, Li R, Pan Y, Gao T, Deng Q, Sun H, Song G, Wang S. Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies. PLoS One 2014;9:e90090. [PMID: 24598538 DOI: 10.1371/journal.pone.0090090] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
12 Wang Z, Wen P, Luo X, Fang X, Wang Q, Ma F, Lv J. Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population. Tumour Biol 2014;35:3605-10. [PMID: 24310504 DOI: 10.1007/s13277-013-1475-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
13 Mirabello L. Osteosarcoma: Genetics of Inherited Susceptibility. eLS 2013. [DOI: 10.1002/9780470015902.a0023880] [Reference Citation Analysis]
14 Zhong-Xing Z, Yuan-Yuan M, Hai Zhen M, Jian-Gang Z, Li-Feng Z. FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls. PLoS One 2013;8:e73700. [PMID: 24014103 DOI: 10.1371/journal.pone.0073700] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
15 Savage SA, Mirabello L, Wang Z, Gastier-Foster JM, Gorlick R, Khanna C, Flanagan AM, Tirabosco R, Andrulis IL, Wunder JS, Gokgoz N, Patiño-Garcia A, Sierrasesúmaga L, Lecanda F, Kurucu N, Ilhan IE, Sari N, Serra M, Hattinger C, Picci P, Spector LG, Barkauskas DA, Marina N, de Toledo SR, Petrilli AS, Amary MF, Halai D, Thomas DM, Douglass C, Meltzer PS, Jacobs K, Chung CC, Berndt SI, Purdue MP, Caporaso NE, Tucker M, Rothman N, Landi MT, Silverman DT, Kraft P, Hunter DJ, Malats N, Kogevinas M, Wacholder S, Troisi R, Helman L, Fraumeni JF Jr, Yeager M, Hoover RN, Chanock SJ. Genome-wide association study identifies two susceptibility loci for osteosarcoma. Nat Genet 2013;45:799-803. [PMID: 23727862 DOI: 10.1038/ng.2645] [Cited by in Crossref: 146] [Cited by in F6Publishing: 160] [Article Influence: 14.6] [Reference Citation Analysis]
16 Hashemi M, Fazaeli A, Ghavami S, Eskandari-Nasab E, Arbabi F, Mashhadi MA, Taheri M, Chaabane W, Jain MV, Łos MJ. Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases. PLoS One 2013;8:e53075. [PMID: 23326385 DOI: 10.1371/journal.pone.0053075] [Cited by in Crossref: 54] [Cited by in F6Publishing: 61] [Article Influence: 5.4] [Reference Citation Analysis]
17 Joyner DE, Jones KB, Lessnick SL, Schiffman JD, Randall RL. Potential for modulation of the fas apoptotic pathway by epidermal growth factor in sarcomas. Sarcoma 2011;2011:847409. [PMID: 22135505 DOI: 10.1155/2011/847409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Mirabello L, Yu K, Berndt SI, Burdett L, Wang Z, Chowdhury S, Teshome K, Uzoka A, Hutchinson A, Grotmol T, Douglass C, Hayes RB, Hoover RN, Savage SA; National Osteosarcoma Etiology Study Group. A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma. BMC Cancer 2011;11:209. [PMID: 21619704 DOI: 10.1186/1471-2407-11-209] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 4.6] [Reference Citation Analysis]
19 Savage SA, Mirabello L. Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma 2011;2011:548151. [PMID: 21437228 DOI: 10.1155/2011/548151] [Cited by in Crossref: 152] [Cited by in F6Publishing: 171] [Article Influence: 12.7] [Reference Citation Analysis]
20 Mirabello L, Berndt SI, Seratti GF, Burdett L, Yeager M, Chowdhury S, Teshome K, Uzoka A, Douglass C, Hayes RB, Hoover RN, Savage SA; National Osteosarcoma Etiology Study Group. Genetic variation at chromosome 8q24 in osteosarcoma cases and controls. Carcinogenesis 2010;31:1400-4. [PMID: 20530236 DOI: 10.1093/carcin/bgq117] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
21 Qiu LX, Shi J, Yuan H, Jiang X, Xue K, Pan HF, Li J, Zheng MH. FAS -1,377 G/A polymorphism is associated with cancer susceptibility: evidence from 10,564 cases and 12,075 controls. Hum Genet 2009;125:431-5. [PMID: 19225810 DOI: 10.1007/s00439-009-0639-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]